ESMO Immuno-Oncology Congress 2019: Programme

The ESMO Immuno-Oncology Congress 2019 programme is now online!

The ESMO Immuno-Oncology Congress is an annual event devoted entirely to the development and use of the immunotherapies against cancer. It provides a comprehensive overview of everything you need to know in this fast-moving field, from recent advances to those in the pipeline.

Delegates at the ESMO Immuno-Oncology Congress 2019 now also have the opportunity to take part in a special primer taking place prior to the Congress, on 10 December.

The primer, organized by the Society for Immunotherapy of Cancer (SITC) and ESMO, will provide education on introductory immunology and immunotherapy.

View the online programme

Accreditation

ESMO-MORA: The ESMO Immuno-Oncology Congress 2019 programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See  here for further details.

Webcasts 

The Congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.